Larvol Delta - CB103-With-Either-Lenvatinib-or-Abemaciclib-in-Patients-With-NOTCH-ACC

limantrafin (CB-103) - Cellestia Biotech

Lenvima (lenvatinib) - Eisai, Merck (MSD)

Verzenio (abemaciclib) - Eli Lilly

http://clinicaltrials.gov/ct2/show/NCT05774899

Jun 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next